worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Research and Development (R&D)

Novartis Research and Development (R&D)

Drug discovery and development process 

Our interactive chart shows the various steps of drug discovery and development, from target selection to registration.

Novartis Institutes for BioMedical Research (NIBR)

Novartis Institutes for BioMedical Research (NIBR) 

The Novartis Institutes for BioMedical Research (NIBR) is a global research organization committed to discovering innovative medicines that treat disease and improve human health.

Pharmaceutical Development 

Novartis Pharmaceutical Development evaluates drug candidates and proves them to be high-quality therapies with superior value to patients.

Novartis Biologics

Novartis Biologics 

As part of Pharmaceutical Development, Novartis Biologics is dedicated to delivering targeted biologic therapies that can improve the lives of patients around the world.

Corporate Research 

Novartis Corporate Research is striving to address unmet medical needs by leveraging the specific scientific knowledge of the four corporate research institutes: FMI, GNF, NITD and NVGH.

Corporate Research locations

Research and Development locations 

Discover our research and development locations worldwide.

 

During 2008, Novartis increased research and development investments by 12% to USD 7.2 billion. This is one of the highest figures in the industry relative to sales (17.4%).

In 2008, our access-to-medicines programs, valued at USD 1.26 billion, reached 74 million patients.

Clinical pipeline

Clinical pipeline

Our product pipeline has 149 projects in various stages of clinical development.

Latest news

Careers

Our success depends on the creativity and performance of our associates.